Clinical Trials Logo

Filter by:
NCT ID: NCT05537116 Enrolling by invitation - Driving Impaired Clinical Trials

Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving

Start date: October 18, 2022
Phase: N/A
Study type: Interventional

Substance-Impaired Driving among emerging adults remains a significant public health concern and may be the single riskiest substance-related outcome among young adults. Brief Interventions (BIs) have been shown to reduce alcohol-impaired driving among this age group, but are not often implemented - despite their demonstrated efficacy - because it is not economically feasible to deliver in-person BIs to all emerging adult substance users. The present study will be the first to examine whether a text-messaging-based cannabis-impaired driving BI significantly decreases cannabis-impaired driving among emerging adult cannabis users compared to an informational control. Participants will be 240 emerging adults who endorse driving after cannabis use (or combined alcohol and cannabis use) at least three times in the past 3 months. After completing baseline measures, participants will be randomly assigned to receive either: a) substance use information, b) a substance-impaired driving personalized feedback intervention, or c) a substance-impaired driving personalized feedback intervention plus interactive text messages. Participants will complete outcome measures 3 and 6 months post-intervention. Repeated measures mixed modeling analyses will be used to determine whether the intervention significantly reduces substance-impaired driving over time. The project has two specific aims: 1) to evaluate a text based cannabis-impaired driving intervention in a randomized clinical trial, and 2) to determine whether the use of interactive text-messages sustains intervention effects over time.

NCT ID: NCT05536453 Enrolling by invitation - Clinical trials for Degenerative Disc Disease (DDD)

Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine

Start date: August 16, 2022
Phase:
Study type: Observational

The objective of this retrospective study is an investigational clinical follow-up, of patients treated with interbody fusion devices (IBFD), both expandable (EXP) and static (STC), according to their intended use and cleared labeling to understand IBFD design and technique characteristics that affect occurrence rates of subsidence. Patients treated with IBFD's (both EXP and STC) according to their intended use and cleared labeling 1. EXP IBFD's that expand in width and height demonstrate reduced occurrence of subsidence post-operatively when compared to EXP IBFD's that expand in height only and STC IBFD's. 2. EXP IBFD's that are comprised of multi-material composition with Polyetheretherketone (PEEK) endplate contacting surfaces demonstrate reduced occurrence of subsidence on post-operative radiographs when compared to EXP and STC IBFD's that are primarily comprised of Ti with Ti endplate contacting surfaces. 3. achieve radiographic fusion at a rate consistent with the state-of-the-art 4. achieve significant improvements in pain and function compared to baseline 5. experience adverse events at a frequency comparable to reported rates for TLIF or PLIF surgery 6. not demonstrate any intraoperative complications during the implant process 7. operative approach does not correlate with increased rates of subsidence

NCT ID: NCT05535478 Enrolling by invitation - Diabetes Clinical Trials

Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's

Start date: January 31, 2023
Phase: N/A
Study type: Interventional

Objectives To 1) examine the ability of the STRIDE (Simplification of Treatment Regimens and Individualized Diabetes Education) educational program to increase deprescribing of high hypoglycemia risk glucose-lowering medications (HRMs) among long term care facility (LTCF) residents with ADRD, 2) assess key implementation constructs (secondary outcomes) of the STRIDE program, including acceptability, appropriateness, and feasibility, and 3) validate the primary HRM use outcome measure.

NCT ID: NCT05534516 Enrolling by invitation - Clinical trials for Acute Illness Requiring to Hospital Telemetry Admission

A Study of Physiologic Changes in a Telemetry Unit

Start date: February 22, 2023
Phase:
Study type: Observational

The purpose of this study is to determine the physiological changes associated with health deterioration, as well as different types, doses, and routes of administration of medications and fluids in acutely ill patients.

NCT ID: NCT05534477 Enrolling by invitation - Chronic Disease Clinical Trials

Verily Clinical Study Watch Analytical Validation Study

Start date: September 18, 2023
Phase:
Study type: Observational

This study is designed to evaluate the performance of the Verily Clinical Study Watch for the quantification of participants' movement and pulse rate when the wearer is at rest.

NCT ID: NCT05534425 Enrolling by invitation - Clinical trials for Virus Infection, RNA

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange

GenX
Start date: September 26, 2022
Phase: N/A
Study type: Interventional

This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.

NCT ID: NCT05533866 Enrolling by invitation - Clinical trials for Epidermolysis Bullosa

Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution

Start date: February 6, 2023
Phase: Early Phase 1
Study type: Interventional

In this pilot study, APR-TD011 antimicrobial wound cleansing spray will be given to all enrolled patients with junctional EB (JEB) or dystrophic epidermolysis bullosa (DEB) with Staphylococcus aureus or Pseudomonas aeruginosa culture-positive wounds. The primary aim will be to evaluate the change in skin microbiome (S. aureus, P. aeruginosa, commensal organisms) before, during, after treatment. Subjects who are colonized by S. aureus or pseudomonas will be treated for 8 weeks, will stop the spray and return at 12 weeks (4 weeks without the spray), and then will be able to use the spray as desired in a 6-month period of open-label use, with further feedback collected.

NCT ID: NCT05532683 Enrolling by invitation - Psychosis Clinical Trials

Feasibility Trial of a Lifestyle Intervention for CHR-P

Start date: April 4, 2023
Phase: N/A
Study type: Interventional

The present study will assess the feasibility and social validity of an adjunctive health promotion group for youth and clinical high risk for psychosis (CHR-P). Youth participating in treatment at the Center for the Assessment and Prevention of Prodromal Sates (CAPPS) will be invited to participate in a weekly, adjunctive, closed psychoeducation group focused on sharing health promotion strategies and increasing health behaviors (e.g. improved sleep habits, increased participation in physical activity). The aim of the group will be to provide psychoeducation on lifestyle risk and protective factors for youth at risk for psychosis (i.e. experiencing subthreshold psychosis symptoms). Topics covered will include psychoeducation, goal setting, stress management, sleep, physical activity, substance use, and nutrition. Evidence-based strategies to decrease risk factors and promote protective lifestyle factors for mental illness will be reviewed. Group leaders will utilize a motivational interviewing approach to facilitate the group. The group will complete nine weekly group sessions. The goal of our research is to 1) determine the feasibility of a novel group-based health promotion intervention, 2) assess the social validity of the group, 3) measure the effects of the intervention on stress, sleep, physical activity, substance use, and nutrition, and 4) measure preliminary effects on symptoms and functioning.

NCT ID: NCT05532657 Enrolling by invitation - Aging Clinical Trials

ACHIEVE Brain Health Follow-Up Study

ACHIEVE-BHFU
Start date: January 12, 2023
Phase: Phase 3
Study type: Interventional

The ACHIEVE Brain Health Follow-Up Study is a 3-year follow-up to the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study to determine the long-term effect of hearing intervention vs. successful aging/delayed hearing intervention on rates of cognitive decline and incident mild cognitive impairment or dementia.

NCT ID: NCT05530863 Enrolling by invitation - Pregnancy Related Clinical Trials

Behavioral Relaxation Approaches for Insomnia in Pregnant Patients

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This study will evaluate the effect of a simplified behavioral relaxation intervention to improve insomnia in pregnant women